Amedeo Smart

Free Medical Literature Service

 

Amedeo

Colorectal Neoplasms
  Free Subscription

Articles published in
Oncogene
    April 2025
  1. WOUTERS VM, Helderman RFCPA, Cameron K, van der Hooff SR, et al
    CDX2 downregulation regulates intrinsic WNT pathway activation, dictating metastasis in APC and CTNNB1 wildtype colorectal cancer.
    Oncogene. 2025 Apr 6. doi: 10.1038/s41388-025-03365.
    >> Share

    March 2025
  2. TAIRA A, Aavikko M, Katainen R, Kaasinen E, et al
    Comprehensive metabolomic and epigenomic characterization of microsatellite stable BRAF-mutated colorectal cancer.
    Oncogene. 2025 Mar 18. doi: 10.1038/s41388-025-03326.
    >> Share

  3. WANG B, Zhang S, Guo Y, Gao W, et al
    CBX2 as a therapeutic target in colorectal cancer: insights into the altered chromatin accessibility via RUNX1-CBX2-MAP4K1 axis.
    Oncogene. 2025 Mar 13. doi: 10.1038/s41388-025-03331.
    >> Share

    February 2025
  4. SHENG Z, Luo S, Huang L, Deng YN, et al
    SENP1-mediated deSUMOylation of YBX1 promotes colorectal cancer development through the SENP1-YBX1-AKT signaling axis.
    Oncogene. 2025 Feb 23. doi: 10.1038/s41388-025-03302.
    >> Share

  5. YAN Z, He L, Yuan J, Niu Y, et al
    The splicing factor SRRM2 modulates two S6K kinases to promote colorectal cancer growth.
    Oncogene. 2025 Feb 16. doi: 10.1038/s41388-025-03307.
    >> Share

  6. ZHANG J, Zhai J, Wong CC, Chen H, et al
    Correction: A novel amplification gene PCI domain containing 2 (PCID2) promotes colorectal cancer through directly degrading a tumor suppressor promyelocytic leukemia (PML).
    Oncogene. 2025 Feb 12. doi: 10.1038/s41388-025-03304.
    >> Share

  7. RUAN DY, Li T, Wang YN, Meng Q, et al
    Correction: FTO downregulation mediated by hypoxia facilitates colorectal cancer metastasis.
    Oncogene. 2025 Feb 4. doi: 10.1038/s41388-025-03287.
    >> Share

    January 2025
  8. REISSLAND M, Hartmann O, Tauch S, Bugter JM, et al
    Correction: USP10 drives cancer stemness and enables super-competitor signalling in colorectal cancer.
    Oncogene. 2025 Jan 22. doi: 10.1038/s41388-024-03262.
    >> Share

    December 2024
  9. LIAO Y, Yang R, Wang B, Ruan Y, et al
    Mevalonate kinase inhibits anti-tumor immunity by impairing the tumor cell-intrinsic interferon response in microsatellite instability colorectal cancer.
    Oncogene. 2024 Dec 26. doi: 10.1038/s41388-024-03255.
    >> Share

    November 2024
  10. ZHUANG M, Liu J, Li Y, Zhang J, et al
    PD-L1 promotes tumor metastasis by regulating the infiltration of FGFBP2(+)Tm cells in colorectal cancer.
    Oncogene. 2024 Nov 18. doi: 10.1038/s41388-024-03223.
    >> Share

  11. WEN M, Qiu Y, Wang M, Tang F, et al
    Enhancing low-dose radiotherapy efficacy with PARP inhibitors via FBL-mediated oxidative stress response in colorectal cancer.
    Oncogene. 2024 Nov 8. doi: 10.1038/s41388-024-03207.
    >> Share

  12. DUYSAK T, Kim K, Yun M, Jeong JH, et al
    Enhanced anti-cancer efficacy of arginine deaminase expressed by tumor-seeking Salmonella Gallinarum.
    Oncogene. 2024;43:3378-3387.
    >> Share

  13. BORDONE R, Ivy DM, D'Amico R, Barba M, et al
    MYC upstream region orchestrates resistance to PI3K inhibitors in cancer cells through FOXO3a-mediated autophagic adaptation.
    Oncogene. 2024;43:3349-3365.
    >> Share

    October 2024
  14. BORDING T, Janik T, Bischoff P, Morkel M, et al
    GPA33 expression in colorectal cancer can be induced by WNT inhibition and targeted by cellular therapy.
    Oncogene. 2024 Oct 29. doi: 10.1038/s41388-024-03200.
    >> Share

  15. REISSLAND M, Hartmann O, Tauch S, Bugter JM, et al
    USP10 drives cancer stemness and enables super-competitor signalling in colorectal cancer.
    Oncogene. 2024 Oct 23. doi: 10.1038/s41388-024-03141.
    >> Share

  16. LIN W, Xu L, Li Y, Li J, et al
    Aberrant FAM135B attenuates the efficacy of chemotherapy in colorectal cancer by modulating SRSF1-mediated alternative splicing.
    Oncogene. 2024 Oct 13. doi: 10.1038/s41388-024-03189.
    >> Share

  17. HAN F, Zhou X, Liu L, Yang B, et al
    GLTSCR1 deficiency promotes colorectal cancer development through regulating non-homologous end joining.
    Oncogene. 2024 Oct 11. doi: 10.1038/s41388-024-03179.
    >> Share

    September 2024
  18. XU H, Wang T, Nie H, Sun Q, et al
    USP36 promotes colorectal cancer progression through inhibition of p53 signaling pathway via stabilizing RBM28.
    Oncogene. 2024 Sep 29. doi: 10.1038/s41388-024-03178.
    >> Share

  19. SUN Z, Dang P, Guo Y, Liu S, et al
    Targeting CircAURKA prevents colorectal cancer progression via enhancing CTNNB1 protein degradation.
    Oncogene. 2024 Sep 28. doi: 10.1038/s41388-024-03155.
    >> Share

  20. TANG W, Yang Y, Fu Z, Xu W, et al
    The RNA helicase DDX21 activates YAP to promote tumorigenesis and is transcriptionally upregulated by beta-catenin in colorectal cancer.
    Oncogene. 2024 Sep 17. doi: 10.1038/s41388-024-03160.
    >> Share

  21. CHURCHHOUSE AMD, Billard CV, Suzuki T, Pohl SOG, et al
    Loss of DOCK2 potentiates Inflammatory Bowel Disease-associated colorectal cancer via immune dysfunction and IFNgamma induction of IDO1 expression.
    Oncogene. 2024 Sep 7. doi: 10.1038/s41388-024-03135.
    >> Share

    August 2024
  22. GUPTA A, Avadhanula S, Bashyam MD
    Evaluation of the gene fusion landscape in early onset sporadic rectal cancer reveals association with chromatin architecture and genome stability.
    Oncogene. 2024;43:2449-2462.
    >> Share

    July 2024
  23. LI X, Chen Y, Lu R, Hu M, et al
    Correction: Colorectal cancer cells secreting DKK4 transform fibroblasts to promote tumour metastasis.
    Oncogene. 2024 Jul 15. doi: 10.1038/s41388-024-03101.
    >> Share

    June 2024
  24. GU J, Xu X, Li X, Yue L, et al
    Tumor-resident microbiota contributes to colorectal cancer liver metastasis by lactylation and immune modulation.
    Oncogene. 2024 Jun 18. doi: 10.1038/s41388-024-03080.
    >> Share

  25. FENG M, Chai C, Hao X, Lai X, et al
    Inherited KDM6A(A649T) facilitates tumor-immune escape and exacerbates colorectal signet-ring cell carcinoma outcomes.
    Oncogene. 2024;43:1757-1768.
    >> Share

    April 2024
  26. CAO N, Zhang F, Yin J, Zhang J, et al
    LPCAT2 inhibits colorectal cancer progression via the PRMT1/SLC7A11 axis.
    Oncogene. 2024 Apr 11. doi: 10.1038/s41388-024-02996.
    >> Share

  27. WU Q, Wang Z, Chen S, She X, et al
    USP26 promotes colorectal cancer tumorigenesis by restraining PRKN-mediated mitophagy.
    Oncogene. 2024 Apr 2. doi: 10.1038/s41388-024-03009.
    >> Share

    March 2024
  28. LI X, Chen Y, Lu R, Hu M, et al
    Colorectal cancer cells secreting DKK4 transform fibroblasts to promote tumour metastasis.
    Oncogene. 2024 Mar 22. doi: 10.1038/s41388-024-03008.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016